ARCHIVES

FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly.

This article is from The Cancer Letter archive.

Vol. 31 No. 18 | May 6, 2005

Download PDF Visit The Full Archive

Related Articles

Letter to the Editors: Researchers Must Keep Up NIH Advocacy Particularly Now

October 11, 1996

MIT Researcher Ingested P-32; NRC Investigating

October 27, 1995

Elderly Men Say Physicians Are Recommending PSA Tests

December 26, 2003

Chabner Object To Yarbro’s Remarks On Federal Role In Clinical Research

April 15, 1983

In Brief: Henney Names Acting Director Of DRCCA: House Bill Would Slash Deeply Into Research Using Animals

September 11, 1981

Fischinger Names Research VP at MUSC (Charleston); Meyskens Names Director Of New UC (Irvine Center)

October 28, 1988